Skip to main content
. 2013 Jan 4;68(7):828–836. doi: 10.1093/gerona/gls258

Table 3.

Mean (SE) Data for Knee Extensor Strength and Leg Press Power in Men and Women Before and After Weight Loss, According to Main Intervention Arm

Pioglitazone No Pioglitazone RT No RT
Women
    Mean KE strength (Nm)
      Baseline 56.8 (3.4) 53.3 (5.2) 51.2 (4.8) 59.0 (3.8)
      Follow-up* 59.5 (3.3) 55.9 (3.3) 61.5 (3.3) 53.8 (3.5)
      LS change (95% CI) from baseline* 3.9 (−1.9, 10.7) 0.3 (−6.5, 7.1) 5.9 (−0.8, 12.5) −1.7 (−8.7, 5.3)
      Between-group difference*,† (95% CI) 3.6 (−6.1, 13.2); p = .45 7.6 (−2.2, 17.4); p = .12
    Mean LP power (W)
      Baseline 41.8 (4.2) 47.8 (5.5) 38.0 (4.2) 51.6 (5.1)
      Follow-up* 71.1 (4.7) 62.8 (4.8) 81.6 (4.7) 52.3 (4.9)
      LS change (95% CI) from baseline* 26.0 (16.5, 35.5) 17.7 (7.9, 27.4) 36.5 (26.8, 46.1) 7.2 (−2.7, 17.1)
      Between-group difference*,† (95% CI) 8.3 (−5.3, 22.0); p = .22 29.3 (15.2, 43.4); p < .001
Men
      Mean KE strength (Nm)
      Baseline 109.3 (6.1) 106.9 (5.5) 112.9 (7.4) 103.4 (3.6)
      Follow-up* 102.9 (6.4) 108.0 (6.2) 103.1 (6.3) 107.7 (6.4)
      LS change (95% CI) from baseline* −8.0 (−20.9, 5.0) −2.9 (−15.5, 9.7) −7.8 (−20.5, 5.0) −3.1 (−16.1, 9.9)
      Between-group difference*,† (95% CI) −5.1 (−23.1, 13.0); p = .58 −4.7 (−23.0, 13.7); p = .61
    Mean LP power (W)
      Baseline 104.3 (7.2) 92.9 (8.2) 96.0 (7.3) 101.2 (8.3)
      Follow-up* 107.2 (8.7) 121.8 (8.7) 124.5 (8.5) 104.5 (8.9)
      LS change (95% CI) from baseline* 7.4 (−10.2, 25.0) 22.0 (4.4, 39.5) 24.7 (7.5, 41.8) 4.6 (−13.3, 22.6)
      Between-group difference*,† (95% CI) −14.6 (−39.6, 10.4); p = .25 20.0 (−4.9, 45.0); p = .11

Note. LP, leg press; KE, knee extensor; RT, resistance training; CI, confidence interval; LS, least squares.

*Follow-up means, measures of change, and between-group differences are adjusted for main effects and baseline measure.

Differences are change in treatment group minus change in control group.